InvestorsHub Logo
Post# of 252302
Next 10
Followers 833
Posts 119891
Boards Moderated 17
Alias Born 09/05/2002

Re: None

Wednesday, 10/26/2005 10:47:09 PM

Wednesday, October 26, 2005 10:47:09 PM

Post# of 252302
Two Successful Pregnancies following
Eight Miscarriages in a Patient with
Antithrombin Deficiency:


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_...

>>
Gynecol Obstet Invest. 2005 Oct 21;61(2):111-114 [Epub ahead of print]

Szilagyi A, Nagy A, Tamas P, Vizer M, Szabo I, Losonczy H.

Department of Obstetrics and Gynecology, University of Pecs, Pecs, Hungary.

Inherited thrombophilias are associated with an increased risk of maternal thromboembolism and certain adverse pregnancy outcomes, including second- and third-trimester fetal loss, placental abruption, severe intrauterine growth restriction, and early-onset, severe preeclampsia. Pregnant patients with severe thrombophilias, especially antithrombinopathies are at very high risk for both thromboembolism and adverse pregnancy outcomes.

A case of a patient with antithrombin deficiency is reported, who had two successful pregnancies after eight miscarriages. Our case shows that a combined treatment with antithrombin substitution and a prophylactic, body-weight-adjusted dose of low-molecular-weight heparin may be successful in preventing pregnancy loss and thromboembolism in antithrombin deficiency during pregnancy, although other complications, such as preeclampsia and intrauterine growth restriction cannot always be prevented.
<<

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.